New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
LB Pharmaceuticals Inc (LBRX) vs Novavax, Inc. (NVAX)
- LB Pharmaceuticals Inc LBRX 38.74 −3.20%
- Novavax, Inc. NVAX 7.74 +0.13%
LB Pharmaceuticals Inc and Novavax, Inc. are both Biotechnology companies. LB Pharmaceuticals Inc and Novavax, Inc. are of similar size ($1.3B and $1.3B). LB Pharmaceuticals Inc has the higher net margin (0.00% vs −18.6%) and the lower return on invested capital (−686.2% vs 0.00%). Across the 12 metrics below, Novavax, Inc. leads on 7 and LB Pharmaceuticals Inc on 5.
Valuation
Profitability
| Metric | LBRX | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 78.01% | 70.18% |
| Operating margin | 0.00% | (21.23%) | 0.00% |
| Net margin | 0.00% | (18.64%) | 0.00% |
| Free cash flow margin | 0.00% | (59.09%) | 0.00% |
| Return on equity | (38.80%) | 41.08% | (51.58%) |
| Return on assets | (36.48%) | (7.42%) | (45.91%) |
| Return on invested capital | (686.18%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack